EMEA-001878-PIP01-15 - paediatric investigation plan

Finasteride

Key facts

• Active Substance:
  Finasteride
• Therapeutic area:
  Dermatology
• Decision number:
  P/0113/2016
• PIP number:
  EMEA-001878-PIP01-15
• Pharmaceutical form(s):
  • Cutaneous spray
  • Solution
• Condition(s) / indication(s):
  Treatment of androgenetic alopecia
• Route(s) of administration:
  Cutaneous use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  15/04/2016

Decision

P/0113/2016: EMA decision of 15 April 2016 on the granting of a product specific waiver for finasteride (EMEA-001878-PIP01-15)

AdoptedReference Number: EMA/203924/2016